SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
Vertex presents positive data at the American Diabetes Association (ADA) Scientific Sessions on investigational treatment for type 1 diabetes
Vertex to announce second quarter 2023 financial results on August 1
Vertex and Lonza announce collaboration to build dedicated production facility for investigational type 1 diabetes cell therapies
Vertex announces the FDA has accepted the applications for our potential treatment for sickle cell disease and transfusion-dependent beta thalassemia
Vertex and CRISPR Therapeutics present positive data at the European Hematology Association (EHA) Congress on investigational program for the treatment of sickle cell disease and beta thalassemia
Working at Vertex
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Featured Stories
Chief Human Resources Officer Stephanie Franklin discusses our unique culture at Vertex and how we bring our culture to life.
Step inside our Oxford, U.K., Learning Lab and learn about our year 12 summer internship, one of our signature STEAM education programs.
Learn about how mRNA therapy could potentially benefit people living with serious diseases.
Chief Human Resources Officer Stephanie Franklin discusses our unique culture at Vertex and how we bring our culture to life.
Step inside our Oxford, U.K., Learning Lab and learn about our year 12 summer internship, one of our signature STEAM education programs.
Learn about how mRNA therapy could potentially benefit people living with serious diseases.
